Next Article in Journal
Transcriptional Induction of Metallothionein by Tris(pentafluorophenyl)stibane in Cultured Bovine Aortic Endothelial Cells
Next Article in Special Issue
Effects of Hormone Therapy on Oxidative Stress in Postmenopausal Women with Metabolic Syndrome
Previous Article in Journal
Antiplatelet Usage Impacts Clot Density in Acute Anterior Circulation Ischemic Stroke
Previous Article in Special Issue
Spectrophotometric Determination of Phenolic Antioxidants in the Presence of Thiols and Proteins
Article Menu
Issue 9 (September) cover image

Export Article

Open AccessReview
Int. J. Mol. Sci. 2016, 17(9), 1379; doi:10.3390/ijms17091379

Micronutrient Antioxidants and Nonalcoholic Fatty Liver Disease

Department of Cell Metabolism and Nutrition, Brain/Liver Interface Medicine Research Center, Kanazawa University, Kanazawa, Ishikawa 920-8640, Japan
*
Author to whom correspondence should be addressed.
Academic Editor: Maurizio Battino
Received: 26 July 2016 / Revised: 12 August 2016 / Accepted: 17 August 2016 / Published: 23 August 2016
(This article belongs to the Special Issue Macro- and Micro-nutrient Antioxidants)
View Full-Text   |   Download PDF [928 KB, uploaded 23 August 2016]   |  

Abstract

Nonalcoholic fatty liver disease (NAFLD) is one of the most important chronic liver diseases worldwide and has garnered increasing attention in recent decades. NAFLD is characterized by a wide range of liver changes, from simple steatosis to nonalcoholic steatohepatitis, cirrhosis, and hepatocellular carcinoma. The blurred pathogenesis of NAFLD is very complicated and involves lipid accumulation, insulin resistance, inflammation, and fibrogenesis. NAFLD is closely associated with complications such as obesity, diabetes, steatohepatitis, and liver fibrosis. During the progression of NAFLD, reactive oxygen species (ROS) are activated and induce oxidative stress. Recent attempts at establishing effective NAFLD therapy have identified potential micronutrient antioxidants that may reduce the accumulation of ROS and finally ameliorate the disease. In this review, we present the molecular mechanisms involved in the pathogenesis of NAFLD and introduce some dietary antioxidants that may be used to prevent or cure NAFLD, such as vitamin D, E, and astaxanthin. View Full-Text
Keywords: nonalcoholic fatty liver disease (NAFLD); nonalcoholic steatohepatitis (NASH); antioxidants; insulin resistance; inflammation; fibrosis; vitamin D; vitamin E; astaxanthin nonalcoholic fatty liver disease (NAFLD); nonalcoholic steatohepatitis (NASH); antioxidants; insulin resistance; inflammation; fibrosis; vitamin D; vitamin E; astaxanthin
Figures

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Chen, G.; Ni, Y.; Nagata, N.; Xu, L.; Ota, T. Micronutrient Antioxidants and Nonalcoholic Fatty Liver Disease. Int. J. Mol. Sci. 2016, 17, 1379.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top